Drug intelligence / Profile preview

HcKCR1

Development stage
Preclinical
Lead developer
University of Texas Health Science Center at Houston
Modality
Gene Therapies
Administration
Parenteral
01

Overview

HcKCR1 (kalium channelrhodopsin 1) is a natural light-gated, potassium-selective channelrhodopsin originally discovered in the stramenopile protist *Hyphochytrium catenoides*. It functions as a highly selective potassium channel that opens rapidly (in less than 1 ms) upon illumination with green light (peak activation around 540 nm). Unlike classical potassium channels, HcKCR1 lacks the canonical TVGYG selectivity filter, instead utilizing an alternative asymmetric selectivity gate to discriminate potassium from sodium. When expressed in excitable cells such as neurons or cardiomyocytes via adeno-associated virus (AAV) vectors, photoactivation of HcKCR1 drives potassium efflux, leading to membrane hyperpolarization and robust silencing of action potentials. HcKCR1 is widely investigated as an inhibitory optogenetic tool and a potential gene therapy candidate for the treatment of hyperexcitability-associated neurological and cardiac disorders, including epilepsy, Parkinson's disease, neuropathic pain, and cardiac arrhythmias.

Other names
Hyphochytrium catenoides kalium channelrhodopsin 1KCR1KCR-1KCR 1kalium channelrhodopsin 1

Beyond the preview

Go deeper on HcKCR1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HcKCR1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call